MSCI China All Shares IMI Biotech Advance Index
The MSCI China All Shares IMI Biotech Advance Index aims to represent the performance of a set of companies across large, mid and small cap representation in China A‐shares, B‐shares, H‐shares, Red‐chips, and P‐chips that are associated with research, development, and commercialization of products for treating a broad range of diseases and disorders.
Data as of Sept. 30, 2024
ESG metrics
Summary
MSCI China All Shares IMI Biotech Advance Index
Implied Temperature Rise
> 1.5°C - < 2°C
73.91% coverage
MSCI ACWI IMI
Implied Temperature Rise
> 2.0°C - < 3.2°C
94.69% coverage
(*) Additional ESG factor not mentioned in the regulation but provided for transparency purposes.
Data available as of Sept. 30, 2024. The information was updated as part of the regular monthly update cycle.
MSCI ESG and climate ratings, research and data are produced by MSCI ESG Research LLC, a subsidiary of MSCI Inc. MSCI ESG Indexes, Analytics, Real Assets, and Private Capital Solutions are products of MSCI Inc. that utilize information from MSCI ESG Research LLC. MSCI Indexes are administered by MSCI Limited and MSCI Deutschland GmbH.